Comparing HIV levels in blood and lymph node tissue
Observes HIV in blood and lymph node samples from adults living with HIV.
Key facts
- Who runs it
- National Institute of Allergy and Infectious Diseases (NIAID)
- Where
- Bethesda, United StatesSee the site
- Trial code
- Registry title
- Viral Load in Blood and Lymph Tissues in People Living With HIV
- Status
- Recruiting
- People taking part
- 400 people, planned
- Started
- 26 Aug 1992
- Type of study
- Observational, 2 groups
- Record updated
- 16 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults living with HIV, and adults without HIV as control participants. It compares the virus in blood and lymph node tissue.
- Age
- 18 years or older (up to 100 years)
- Sex
- All
- Disease stage
- People with HIV need documented HIV status. People with AIDS dementia or an AIDS-related cancer other than minimal Kaposi's sarcoma cannot join.
- Earlier treatment
- No aspirin or non-aspirin anti-inflammatory medicines such as ibuprofen or naproxen for 7 days before the biopsy. Acetaminophen is allowed.
- Biomarker or test result
- HIV status confirmed by ELISA plus Western blot or plasma viremia. Blood counts and clotting tests must be in the ranges set in the record. Participants must allow genetic and hepatitis testing.
Main reasons for not taking part
- Pregnant or breast-feeding women
- Current alcohol or drug abuse, including narcotics or cocaine
- AIDS dementia, or an AIDS-related cancer other than minimal Kaposi's sarcoma
- Planned sedation for the biopsy
- A medical condition that the doctor in charge thinks makes a lymph node biopsy unsafe
The registry criteria, word for word
Show all 7 criteriaShow less
Who cannot take part
- Currently abusing alcohol or other drugs including narcotics or cocaine
- No Aspirin or Non-Steroidal Anti-inflammatory medications (NSIADs) 7 days prior to procedure. Acetaminophen (Tylenol) is permitted at any time
- Participants in which sedation is planned. Use of narcotics (other than as prescribed by a physician) or cocaine less than 1 week prior to the date of biopsy will be excluded
- Participants with AIDS dementia or with an AIDS related malignancy other than minimal Kaposi's sarcoma
- Any medical condition for which the PI feels LN BX might be contraindicated
- Women who are pregnant and/or breast-feeding
Other criteria
- INCLUSION CRITERIA:; HIV status must be documented by a licensed ELISA and confirmed either by Western blot, or plasma viremia; Aged 18 years or older; Ability to give informed, written consent; The following laboratory values:; Absolute neutrophil count of greater than 1000/mm\^3; PT, PTT, within normal limits, (unless PTT is elevated in presence of positive lupus anticoagulant in a participant with no prior history of abnormal bleeding); Adequate blood counts (PLWH: hemoglobin >= 9.0 g/dL, HCT >= 28%, platelets >= 75,000; participants without HIV: hemoglobin >=11.2 g/dL, HCT >=34.1%, platelets >=150,000); Blood pressure <=180/100; pulse rate 50-100, unless a lower pulse rate is considered normal for the participant; Participants who do not have HIV will qualify as control participants; Participants must have a clinically palpable lymph node in an easily accessible location; Willingness to allow blood samples to be used for future studies of HIV infection/pathogenesis, undergo genetic testing including HLA testing, and undergo hepatitis screening
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
Where in United States
- National Institutes of Health Clinical CenterBethesda, United StatesContact: Catherine A Seamon, R.N.Taking people
About the trial
What the trial wants to find out
This is a study to determine the effect of the human immunodeficiency virus (HIV) on lymphoid tissues (e.g., lymph nodes) as compared to peripheral white blood cells. We have shown in previous studies that the lymph node is a major site of accumulation of HIV in the body, as well as being a site where much of the viral replication occurs which leads to the destruction of the body's immune system. To better understand the role of the lymph node in HIV infection and destruction of one s immunity, we wish to examine both the virus itself as well as the effects it is having on various types of white cells (called lymphocytes) obtained simultaneously from both peripheral blood and lymph nodes of people living with HIV (PLWH). We also need to look at cells derived from blood and lymph nodes from people who do not have HIV to serve as a control for experiments. We may also use your lymph node tissue and blood cells to attempt to make new T-cells, or rebuild the immune cells, in the laboratory by adding various factors or other substances released by different cells in the body. If you are living with HIV, you may be asked to undergo a second biopsy six weeks to 12 months after the first biopsy. Because of the ability of aspirin to interfere with blood clotting, you must have refrained from the use of aspirin for one week (7 days) prior to the biopsy date. You also cannot use non-aspirin containing, non-steroidal, anti-inflammatory medications (e.g., ibuprofen, naproxen, and similar drugs) one week (7 days) prior to the biopsy. In addition, pregnancy testing will be performed on all females at the time of admission and a positive test will exclude you from participation. No participant will undergo more than six biopsies while participating in this study unless a particular research requires it.
The 2 groups in the trial
- Individuals with HIV
- Individuals without HIV
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Study of Viral Burden in Peripheral Blood Versus Lymphoid and Bone Marrow Tissue in People Living With HIV
- Plain-language title
- Comparing HIV levels in blood and lymph node tissueGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT00001316, who can take part
- Record updated
- 16 October 2026